Extracellular matrix synthesis and tissue elasticity research

Hydrolysed Collagen Peptides Evidence: 85 Verified Research Papers

Hydrolysed collagen contains enzymatically fragmented collagen proteins. Digestion releases amino acids and a subset of hydroxyproline-containing peptides detectable in human blood. Clinical effects depend on peptide preparation, dose, comparator and outcome; skin trials conflict when funding and trial quality are considered, while joint and tendon studies mix distinct collagen forms or training protocols.

Evidence at a glance

17
Tier 1
42
Tier 2
20
Tier 3
6
Tier 4

Bioavailability

Tier 4

Assessment of bioavailability after in vitro digestion and first pass metabolism of bioactive peptides from collagen hydrolysates

Christina E. Larder et al. · Current Issues in Molecular Biology · 2021 · 43(3):1592–1605

Preclinical in-vitro digestion, intestinal-transport and hepatic first-pass model using HIEC-6 human intestinal epithelial cells and HepG2 hepatocytes. It measures peptide recovery and simulated bioavailability, not clinical efficacy or in-vivo human absorption.

Sourcedoi:10.3390/cimb43030113PMID 34698092PMC8928955

Bioavailability; intact-peptide exposure

Tier 3

Absorption of bioactive peptides following collagen hydrolysate intake: a randomized, double-blind crossover study in healthy individuals

Nicolina Virgilio et al. · Frontiers in Nutrition · 2024 · 11:1416643

Randomized double-blind four-treatment crossover pharmacokinetic pilot; N=6, only acute exposure and manufacturer-supplied hydrolysates, no functional clinical outcome or direct test of DoNotAge powder; absorption is not equivalent to clinical effect

Sourcedoi:10.3389/fnut.2024.1416643PMID 39149544PMC11325589

Biology and biochemistry

Bone

Bone and muscle; confounded combinations

Bone health

Tier 3

Effects of Collagen Peptide Supplementation on Bone Turnover, Cytokine, and Inflammatory Markers in Female Distance Runners: A Randomized Pilot Study

Nicholas M. Kuhlman et al. · Frontiers in Nutrition · 2026 · 13:1825906

Small, short-duration pilot RCT (n=22, 4 weeks) explicitly designed to establish preliminary signal and feasibility rather than confirm clinical efficacy; surrogate blood biomarkers only, with no bone density or structural imaging outcomes.

Sourcedoi:10.3389/fnut.2026.1825906PMID 42221768PMC13215932

Collagen biochemistry & mechanism

Tier 3

Vitamin C–Enriched Gelatin Supplementation before Intermittent Activity Augments Collagen Synthesis

Gregory Shaw et al. · American Journal of Clinical Nutrition · 2017 · 105(1):136-143

Randomised, double-blinded, crossover trial with independent academic (non-industry) funding and no disclosed conflicts of interest, but the human cohort is very small (n=8) and the primary endpoints are mechanistic/surrogate (circulating amino acids, serum PINP, and an engineered-ligament tissue culture bioassay) rather than a clinical outcome. Tests gelatin plus vitamin C timed around exercise, not a standardised hydrolysed collagen peptide product, so it is included as a mechanism reference rather than direct clinical evidence.

Sourcedoi:10.3945/ajcn.116.138594PMID 27852613PMC5183725

Digestive symptoms; uncontrolled pilot

Tier 3

Effect of a Daily Collagen Peptide Supplement on Digestive Symptoms in Healthy Women: 2-Phase Mixed Methods Study

Mariette Abrahams et al. · JMIR Formative Research · 2022 · 6(5):e36339

Prospective open-label single-arm digital feasibility pilot following exploratory qualitative phase; No placebo/control group, high attrition (26/40), self-report outcomes, limited to women with BMI >25, tested Peptan 20 g not DoNotAge 10 g. Insuffic

Sourcedoi:10.2196/36339PMID 35639457PMC9198822 Trial registry

Gut microbiome; severe burn patients

Joint

Tier 3

Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature

Alfonso E. Bello et al. · Current Medical Research and Opinion · 2006 · 22(11):2221–2232

Peer-reviewed narrative review of preclinical and early clinical collagen-hydrolysate literature. It searched PubMed through May 2006 but also included congress abstracts and German-language literature based on author judgment, with no meta-analysis or formal risk-of-bias framework; therefore it is background synthesis rather than tier-1 efficacy evidence.

Sourcedoi:10.1185/030079906X148373PMID 17076983

Joint health

Tier 2

Effect of Collagen Hydrolysate in Articular Pain: A 6-Month Randomized, Double-Blind, Placebo Controlled Study

Olivier Bruyère et al. · Complementary Therapies in Medicine · 2012 · 20(3):124-130

Single, adequately powered (n=200) double-blind, placebo-controlled RCT with a statistically significant primary endpoint at 6 months but a non-significant result at 3 months, manufacturer funding tied to the tested product, and no benefit shown on validated joint-specific questionnaires.

Sourcedoi:10.1016/j.ctim.2011.12.007PMID 22500661

Tier 2

Effects of Oral Administration of Type II Collagen on Rheumatoid Arthritis

David E. Trentham et al. · Science · 1993 · 261(5129):1727-1730

Single randomised, double-blind, placebo-controlled phase II trial (n=60) with statistically significant but small-sample results and disclosed sponsor-linked financial interests. Tests native, undenatured chicken type II collagen via an oral-tolerance immune mechanism — a different ingredient and mechanism from the hydrolysed collagen peptides this site otherwise reviews.

Sourcedoi:10.1126/science.8378772PMID 8378772

Tier 2

Efficacy and Tolerability of an Undenatured Type II Collagen Supplement in Modulating Knee Osteoarthritis Symptoms: A Multicenter Randomized, Double-Blind, Placebo-Controlled Study

James P. Lugo et al. · Nutrition Journal · 2016 · 15:14

Multicenter, randomised, double-blind, placebo- and active-comparator-controlled trial (n=191) with a 180-day intervention and pre-specified primary/secondary endpoints, but two of three authors are employees of the product's manufacturer and sponsor, a direct financial conflict of interest warranting tier-2 rather than tier-1. Tests undenatured type II collagen (UC-II) — a different ingredient, mechanism and dose scale (milligrams) from the hydrolysed collagen peptides (gram-scale) this site otherwise reviews.

Sourcedoi:10.1186/s12937-016-0130-8PMID 26822714PMC4731911

Tier 2

Improvement of Activity-Related Knee Joint Discomfort Following Supplementation of Specific Collagen Peptides

Denise Zdzieblik et al. · Applied Physiology, Nutrition, and Metabolism · 2017 · 42(6):588-595

Monocentric, prospective, randomised, double-blind, placebo-controlled phase III trial (n=139 completers of 160 randomised), fully funded by the tested product's manufacturer (GELITA Health GmbH), with pre-specified co-primary endpoints and Bonferroni-Holm correction for multiplicity.

Sourcedoi:10.1139/apnm-2016-0390PMID 28177710

Tier 1

Impact of Specific Bioactive Collagen Peptides on Joint Discomforts in the Lower Extremity during Daily Activities: A Randomized Controlled Trial

Claas Schulze et al. · International Journal of Environmental Research and Public Health · 2024 · 21(6):687

Monocentric, prospective, randomised, double-blind, placebo-controlled trial (n=182 randomised, n=154 per-protocol analysed) in a general adult population — not restricted to physically active young adults — with hip and knee joint pain during ordinary daily activities, using Bonferroni-Holm-corrected co-primary endpoints assessed independently by both physician and participant.

Sourcedoi:10.3390/ijerph21060687PMID 38928934PMC11203623

Tier 2

The Influence of Specific Bioactive Collagen Peptides on Knee Joint Discomfort in Young Physically Active Adults: A Randomized Controlled Trial

Denise Zdzieblik et al. · Nutrients · 2021 · 13(2):523

Large randomised, double-blind, placebo-controlled trial (n=218 randomised; n=180 per-protocol) with pre-specified co-primary endpoints assessed by both participant and blinded physician, but the product was manufacturer-supplied and manufacturer-funded, one author has received GELITA-supported lecture fees, and another author joined the manufacturer-linked Collagen Research Institute after the study concluded.

Sourcedoi:10.3390/nu13020523PMID 33562729PMC7915677

Tier 4

Therapeutic Efficacy and Safety of Undenatured Type II Collagen Singly or in Combination with Glucosamine and Chondroitin in Arthritic Dogs

M. D'Altilio et al. · Toxicology Mechanisms and Methods · 2007 · 17(4):189-196

This is a small (n=5/group), double-blinded, placebo-controlled animal (canine) study, not a human trial, using subjective owner/veterinarian pain-scoring rather than validated clinical instruments. Two co-authors are employees of the funding manufacturer. It tests undenatured type II collagen (UC-II) at a microgram dose via a proposed oral-tolerance mechanism in dogs — a fundamentally different ingredient, species, dose scale and mechanism from the hydrolysed collagen peptides this site otherwise reviews — and is included purely as a differentiation reference.

Sourcedoi:10.1080/15376510600910469PMID 20020968

Joints and meniscus

Tier 2

The effect of supplementation with type I and type III collagen peptide and type II hydrolyzed collagen on pain, quality of life and physical function in patients with meniscopathy: a randomized, double-blind, placebo-controlled study

Ahmet Serhat Genç et al. · BMC Musculoskeletal Disorders · 2025 · 26:17

Randomized double-blind placebo-controlled trial, but very small and uses a multi-ingredient formula that prevents collagen-specific attribution.

Sourcedoi:10.1186/s12891-024-08244-wPMID 39755603PMC11699701 Trial registry

Joints and osteoarthritis

Tier 2

Effect of supplementation with type 1 and type 3 collagen peptide and type 2 hydrolyzed collagen on osteoarthritis-related pain, quality of life, and physical function: A double-blind, randomized, placebo-controlled study

Ahmet Serhat Genç et al. · Joint Diseases and Related Surgery · 2025 · 36(1):85-96

Double-blind randomized placebo-controlled trial, but very small and tests a multi-ingredient finished product, so effects cannot be attributed to hydrolysed collagen alone.

Sourcedoi:10.52312/jdrs.2025.1965PMID 39719905PMC11734850

Menopause; skin, hair and bone mixed endpoints

Tier 2

Calcium and Vitamin D Supplementation with and Without Collagen on Bone Density and Skin Elasticity in Menopausal Women-A Randomized Controlled Study

Acharaporn Duangjai et al. · Clinical Practice · 2025 · 15(9):168

Four-arm randomized controlled study comparing collagen, calcium/vitamin D, their combination and placebo; Marine fish formulation, not bovine DoNotAge product. Multi-arm within-group findings should not be mistaken for placebo-adjusted effects; samp

Sourcedoi:10.3390/clinpract15090168PMID 41002783

Muscle

Tier 2

Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: a randomised controlled trial

Denise Zdzieblik et al. · British Journal of Nutrition · 2015 · 114(8):1237–1245

Randomised double-blind placebo-controlled trial with DXA-measured body composition and objective muscle-strength testing in a clinically relevant sarcopenic population. Strong human design, but the 2025 corrigendum documents industry support: Gelita supplied the study product and covered participant-compensation and sample-analysis costs; a co-author was also a patent co-inventor.

Sourcedoi:10.1017/S0007114515002810PMID 26353786PMC4594048

Muscle & body composition

Tier 2

Effects of 12 Weeks of Hypertrophy Resistance Exercise Training Combined with Collagen Peptide Supplementation on the Skeletal Muscle Proteome in Recreationally Active Men

Vanessa Oertzen-Hagemann et al. · Nutrients · 2019 · 11(5):1072

Single double-blind, randomised, placebo-controlled RCT (n=25) with funding tied to the tested product's manufacturer via a closely affiliated research institute; the proteomic outcomes are exploratory/mechanistic rather than confirmatory clinical efficacy data.

Sourcedoi:10.3390/nu11051072PMID 31091754PMC6566884

Tier 2

Prolonged Collagen Peptide Supplementation and Resistance Exercise Training Affects Body Composition in Recreationally Active Men

Marius Kirmse et al. · Nutrients · 2019 · 11(5):1154

Randomised, double-blinded, placebo-controlled trial (n=57 analysed) with a 12-week intervention, muscle biopsies and multiple objective outcome measures, but funded by an industry-affiliated research institute (Collagen Research Institute), a limiting factor for tier-1 status.

Sourcedoi:10.3390/nu11051154PMID 31126103PMC6566878

Tier 2

Specific Collagen Peptides in Combination with Resistance Training Improve Body Composition and Regional Muscle Strength in Premenopausal Women: A Randomized Controlled Trial

Patrick Jendricke et al. · Nutrients · 2019 · 11(4):892

Randomised, double-blind, placebo-controlled trial (n=77 per-protocol) with a 12-week intervention and both per-protocol and intention-to-treat analyses, but the tested product is manufactured by Gelita AG and the paper's own funding disclosure is internally inconsistent (see funding field), which together limit this to tier-2.

Sourcedoi:10.3390/nu11040892PMID 31010031PMC6521629

Muscle and body composition

Tier 2

The Influence of Specific Bioactive Collagen Peptides on Body Composition and Muscle Strength in Middle-Aged, Untrained Men: A Randomized Controlled Trial

Denise Zdzieblik et al. · International Journal of Environmental Research and Public Health · 2021 · 18(9):4837

Randomised, placebo-controlled, double-blind trial with objective DXA body composition and isometric strength endpoints; adequate sample per group with pre-specified power calculation.

Sourcedoi:10.3390/ijerph18094837PMID 33946565PMC8125453

Tier 2

Whey protein but not collagen peptides stimulate acute and longer-term muscle protein synthesis with and without resistance exercise in healthy older women: a randomized controlled trial

Sara Y. Oikawa et al. · The American Journal of Clinical Nutrition · 2020 · 111(3):708–718

Randomised, double-blind, parallel-group trial with gold-standard stable isotope tracer measurement of muscle protein synthesis (the direct mechanistic endpoint) in the target population.

Sourcedoi:10.1093/ajcn/nqz332PMID 31919527PMC7049536

Muscle and exercise

Muscle; direct protein-quality comparator

Tier 2

The effects of whey, pea, and collagen protein supplementation beyond the recommended dietary allowance on integrated myofibrillar protein synthetic rates in older males: a randomized controlled trial

James McKendry et al. · The American Journal of Clinical Nutrition · 2024 · 120(1):34–46

Double-blind randomized controlled feeding trial with deuterated water and muscle biopsies; Short mechanistic trial in older men and not a long-term strength outcome; does not exclude collagen's connective-tissue benefits. Research proteins were not

Sourcedoi:10.1016/j.ajcnut.2024.05.009PMID 38762187PMC11291473

Muscle; indirect collagen versus whey comparisons

Tier 1

Which Protein-Based Dietary Supplements Most Effectively Enhance Fat-Free Mass and Strength Gains in Healthy Adults Undergoing Resistance Training? A Network Meta-Analysis

Marcos D M Drummond et al. · Translational Sports Medicine · 2026 · 2026:5557511

Network meta-analysis of protein interventions plus resistance training; searched through May 2024; Indirect rankings and transitivity assumptions, very different population/training/supplement designs, small collagen nodes and no proof of direct bio

Sourcedoi:10.1155/tsm2/5557511PMID 41635649PMC12862422

Muscle; mixed whey-collagen acute synthesis

Tier 2

Ingestion of a Whey Plus Collagen Protein Blend Increases Myofibrillar and Muscle Connective Protein Synthesis Rates

Thorben Aussieker et al. · Medicine & Science in Sports & Exercise · 2025 · 57(3):544–554

Randomized double-blind placebo-controlled tracer infusion and muscle biopsy study; Acute study, men only, no whey-only arm; product 83% whey. Public–private funded with GELITA involvement, and not a trial of collagen-alone efficacy.

Sourcedoi:10.1249/MSS.0000000000003596PMID 39501478PMC11801439

Musculoskeletal evidence

Nails

Osteoarthritis; direct hydrolysed-collagen RCT

Tier 2

Evaluation of the Efficacy and Safety of CollaSel PRO Type I and Type III Hydrolyzed Collagen Peptides in the Treatment of Osteoarthritis: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial

Devrim Demir-Dora et al. · Journal of Clinical Medicine · 2025 · 14(11):3655

Double-blind randomized parallel placebo-controlled clinical trial in two university physical-medicine centers; Industry-linked authors associated with product supply; proprietary CollaSel PRO not the DoNotAge formulation; 8-week symptom outcomes wit

Sourcedoi:10.3390/jcm14113655PMID 40507417PMC12156922 Trial registry

Osteoarthritis; mixed collagen interventions

Osteoarthritis; null combination-product RCT

Safety

Tier 3

Relationship of Protein Intake to Urinary Oxalate and Glycolate Excretion

Ross P. Holmes et al. · Kidney International · 1993 · 44(2):366-372

Well-controlled academic study combining a large observational cohort (n=101) with a smaller controlled-diet crossover (n=11), with no industry funding or apparent conflicts of interest. Rated tier-3 rather than tier-1/2 because it studies general dietary protein intake — not hydrolysed collagen peptides specifically — and its endpoint (urinary oxalate/glycolate excretion) is a biochemical surrogate for kidney stone risk, not a clinical stone-formation outcome. Included as a background safety reference for readers considering higher-dose collagen peptide (i.e., concentrated protein) intake, alongside massey-2003-urinary-oxalate-kidney-stones.

Sourcedoi:10.1038/ki.1993.253PMID 8377380

Tier 3

Safety of Egg Membrane Collagen Peptides as a Novel Food Pursuant to Regulation (EU) 2015/2283

EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA) et al. · EFSA Journal · 2025 · 23(12):e9709

This is an official EU regulatory scientific opinion by an independent expert panel, based on a manufacturer-submitted compositional and production-process dossier; the Panel concluded no toxicological studies were required given the nature of the novel food. It is not a primary clinical or preclinical research study, so it is rated below tier-1/2 despite its regulatory authority. It concerns egg membrane collagen peptides — a distinct raw material and product category (450–500 mg/day proposed dose) from the gram-scale hydrolysed bovine, porcine, marine or fish collagen peptides this site otherwise reviews — and is included as a differentiation and safety reference.

Sourcedoi:10.2903/j.efsa.2025.9709PMID 41346947PMC12673277

Safety; free hydroxyproline and urinary oxalate

Safety; hydroxyproline metabolism and urinary oxalate

Skin

Tier 2

A collagen supplement improves skin hydration, elasticity, roughness, and density: results of a randomized, placebo-controlled, blind study

Liane Bolke et al. · Nutrients · 2019 · 11(10):2494

Controlled, placebo-comparator, single-blind human trial in 72 women with objective skin endpoints. The Methods describe allocation by alternation rather than a concealed random sequence, so the study is better regarded as quasi-randomized/systematically allocated; the tested ELASTEN product was also a multi-ingredient formulation, limiting collagen-specific attribution.

Sourcedoi:10.3390/nu11102494PMID 31627309PMC6835901 Trial registry

Tier 2

An insight into the changes in skin texture and properties following dietary intervention with a nutricosmeceutical containing a blend of collagen bioactive peptides and antioxidants

Licia Genovese et al. · Skin Pharmacology and Physiology · 2017 · 30(3):146–158

Randomised double-blind placebo-controlled trial with objective skin elasticity + histological analysis in a substantial female sample — solid design but industry-funded and multi-ingredient product prevents isolating collagen effect.

Sourcedoi:10.1159/000464470PMID 28528342

Tier 2

Collagen supplementation for skin health: a mechanistic systematic review

Meisam Barati et al. · Journal of Cosmetic Dermatology · 2020 · 19(11):2820–2829

Peer-reviewed systematic review that screened 9,057 records and included 10 publications, with a mechanistic focus on oral collagen and skin health. It did not perform a quantitative meta-analysis, and the small, heterogeneous, uniformly favorable evidence base limits certainty compared with pooled high-quality clinical evidence.

Sourcedoi:10.1111/jocd.13435PMID 32436266

Tier 2

Safety and Efficacy of a Hydrolyzed Collagen Formulation (HYCOS) for Facial Skin Elasticity and Wrinkles: A Randomized, Double-Blind, Placebo-Controlled Trial

Sutthinee Wisutthathum et al. · Journal of Cosmetic Dermatology · 2026 · 25(9):e71121

Randomized double-blind placebo-controlled human trial with objective skin measurements, but the intervention combined collagen with glutathione and vitamin E, preventing collagen-specific attribution.

Sourcedoi:10.1111/jocd.71121 Trial registry

Tier 2

The Effects of Dietary Supplementation with Collagen and Vitamin C and Their Combination with Hyaluronic Acid on Skin Density, Texture and Other Parameters: A Randomised, Double-Blind, Placebo-Controlled Trial

Katja Žmitek et al. · Nutrients · 2024 · 16(12):1908

Three-arm randomized, double-blind, placebo-controlled human trial with objective skin measurements; industry co-funding and a combination formula limit ingredient-specific interpretation.

Sourcedoi:10.3390/nu16121908PMID 38931263PMC11206740 Trial registry

Skin and nails

Skin health

Tier 4

Effect of Vitamin C and Its Derivatives on Collagen Synthesis and Cross-Linking by Normal Human Fibroblasts

N. Boyera et al. · International Journal of Cosmetic Science · 1998 · 20(3):151-158

In vitro cell-culture and three-dimensional lattice model using normal human fibroblasts; no human subjects, no oral supplementation, and no hydrolysed collagen peptides tested. Included as mechanistic background on vitamin C's cofactor role in collagen cross-linking, not as clinical evidence for any collagen peptide product.

Sourcedoi:10.1046/j.1467-2494.1998.171747.xPMID 18505499

Tier 1

Effects of Hydrolyzed Collagen Supplementation on Skin Aging: A Systematic Review and Meta-Analysis

Roseane B. de Miranda et al. · International Journal of Dermatology · 2021 · 60(12):1449-1461

Systematic review and random-effects meta-analysis of 19 RCTs (n=1,125) pooling skin hydration and elasticity outcomes for hydrolysed collagen supplementation, with formal risk-of-bias grading, sensitivity analysis, and a symmetrical funnel plot arguing against publication bias.

Sourcedoi:10.1111/ijd.15518PMID 33742704

Tier 1

Exploring the Impact of Hydrolyzed Collagen Oral Supplementation on Skin Rejuvenation: A Systematic Review and Meta-Analysis

Dian Andriani Ratna Dewi et al. · Cureus · 2023 · 15(12):e50231

Systematic review and meta-analysis of 14 randomised, double-blind, placebo-controlled trials (n=967) following PRISMA and Cochrane Handbook methodology, with formal RoB-2 risk-of-bias assessment, funnel-plot publication-bias check, and pre-specified subgroup analyses by collagen source and supplementation duration.

Sourcedoi:10.7759/cureus.50231PMID 38192916PMC10773595

Tier 2

Ingestion of Bioactive Collagen Hydrolysates Enhance Facial Skin Moisture and Elasticity and Reduce Facial Ageing Signs in a Randomised Double-Blind Placebo-Controlled Clinical Study

Naoki Inoue et al. · Journal of the Science of Food and Agriculture · 2016 · 96(12):4077-4081

Randomised, double-blind, placebo-controlled trial (n=85) comparing two collagen hydrolysates of differing bioactive dipeptide content against placebo, with objective corneometry/cutometry/VisioFace SSA instrumentation and blood safety testing, but two of three authors are employees of the product manufacturer and the trial was conducted at a single site.

Sourcedoi:10.1002/jsfa.7606PMID 26840887

Tier 3

Hydrolyzed Marine Collagen: Emerging Evidence of Benefits via the Oral Route – Review and Insights for Medical Aesthetics Practitioners

Emanuele Bartoletti et al. · Clinical, Cosmetic and Investigational Dermatology · 2025 · 18:3339-3356

Narrative review (explicitly not a full systematic review; authors describe a rigid but non-exhaustive PubMed search restricted to indexed, high-impact journals) of preclinical studies and a small number of methodologically screened human RCTs on hydrolysed marine collagen and skin regeneration, published with funding from a company whose medical director is a co-author and markets a hydrolysed marine collagen supplement — a disclosed, direct commercial conflict of interest.

Sourcedoi:10.2147/CCID.S562518PMID 41393269PMC12701666

Tier 2

The Effect of Oral Collagen Peptide Supplementation on Skin Moisture and the Dermal Collagen Network: Evidence from an Ex Vivo Model and Randomized, Placebo-Controlled Clinical Trials

Jérome Asserin et al. · Journal of Cosmetic Dermatology · 2015 · 14(4):291-301

Two randomised, placebo-controlled clinical trials (pilot n=33; confirmatory n=101) plus ex vivo mechanistic work, with multiple objective instrumental endpoints (corneometry, high-resolution ultrasound, reflectance confocal microscopy), but two of four authors are employed by commercial entities with a direct interest in the tested collagen peptides and no formal funding/COI disclosure is provided in the article.

Sourcedoi:10.1111/jocd.12174PMID 26362110

Skin, osteoarthritis, bone and muscle

Tier 1

Collagen Supplementation for Skin and Musculoskeletal Health: An Umbrella Review of Meta-Analyses on Elasticity, Hydration, and Structural Outcomes

Roshan Ravindran et al. · Aesthetic Surgery Journal Open Forum · 2026 · 8:ojag018

Umbrella review of published systematic reviews and meta-analyses; literature through March 6, 2025; Double counting of RCTs across included meta-analyses is possible. AMSTAR-2 distribution limits certainty; does not supersede the 2025 funding-sensit

Sourcedoi:10.1093/asjof/ojag018PMID 41809116PMC12968778

Skin; funding and risk of bias

Tier 1

Effects of Collagen Supplements on Skin Aging: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Seung-Kwon Myung et al. · The American Journal of Medicine · 2025 · 138(9):1264–1277

Meta-analysis of 23 randomized controlled trials; prespecified subgroup analyses by funding and study quality; Subgroup results may have lower power; pooled interventions are heterogeneous and do not specifically test DoNotAge's finished bovine colla

Sourcedoi:10.1016/j.amjmed.2025.04.034PMID 40324552

Skin; low-certainty favorable studies

Skin; robust sensitivity analysis

Skin; trial risk of bias and tolerability

Tier 1

Efficacy and safety of hydrolyzed collagen supplementation on skin health outcomes: a systematic literature review of randomized controlled trials

Christine Bassila et al. · European Journal of Clinical Nutrition · 2026 · 80(9):867–885

Systematic literature review with Cochrane RoB 2; searched through April 1, 2023; Search ends April 2023 despite 2026 publication, so not the latest primary-trial corpus. Descriptive vote-counting does not substitute for effect estimates. T

Sourcedoi:10.1038/s41430-026-01778-3PMID 42342959

Sports nutrition; tendon and strength

Tier 1

Impact of Collagen Peptide Supplementation in Combination with Long-Term Physical Training on Strength, Musculotendinous Remodeling, Functional Recovery, and Body Composition in Healthy Adults: A Systematic Review with Meta-analysis

Kevin Bischof et al. · Sports Medicine · 2024 · 54(11):2865–2888

Systematic review and random-effects meta-analysis of training/supplementation RCTs; Most participants male; doses, training and vitamin C co-interventions varied; several small industry-specific formulation trials; cannot assume gains reflect myofib

Sourcedoi:10.1007/s40279-024-02079-0PMID 39060741PMC11561013

Tendon adaptation; high-dose collagen

Tendon adaptation; strength distinction

Tier 1

Collagen Supplementation on Tendon-Related Structural and Performance Outcomes: A Systematic Review

Albert Buchalski et al. · Journal of Functional Morphology and Kinesiology · 2026 · 11(1):130

Systematic review of RCTs incorporating resistance/plyometric loading; Very small total sample and extreme male predominance; review authors' GRADE labels require cautious interpretation; not direct evidence for tendon-injury treatment or generic 10-

Sourcedoi:10.3390/jfmk11010130PMID 41900537PMC13028264

Tendon and ligament

Tendon and rate-of-force; women athletes

Tier 2

Collagen Supplementation Augments Strength Training-Induced Gains in Tendon Size and Rate of Force Development in Elite Female Master Field Hockey Athletes

Christopher D Nulty et al. · International Journal of Sport Nutrition and Exercise Metabolism · 2025 · 35(6):510–519

Triple-blind randomized training study in elite female Master athletes; Only 22 high-performance women; combined vitamin C and training, high 30-g dose; performance effect does not establish clinical tendon injury prevention.

Sourcedoi:10.1123/ijsnem.2025-0089PMID 40992424

Tendon morphology; low-dose selected peptides

Tier 2

Specific collagen peptides increase adaptions of patellar tendon morphology following 14-weeks of high-load resistance training: A randomized-controlled trial

Simon Jerger et al. · European Journal of Sport Science · 2023 · 23(12):2329–2339

Randomized placebo-controlled 14-week high-load knee-extensor training study; Selected branded peptide product, men only and exercise co-intervention; do not generalize low-dose effect to every collagen formulation.

Sourcedoi:10.1080/17461391.2023.2232758PMID 37424319

Tendon stiffness; women athletes

Tier 2

High-intensity resistance training and collagen supplementation improve patellar tendon adaptations in professional female soccer athletes

Joonsung Lee et al. · Experimental Physiology · 2025 · 110(11):1551–1560; online August 2024

Randomized pair-matched placebo-controlled pre-season training study; N=11 and confounded with concurrent high-intensity training and vitamin C; not evidence for reduced injury rates or a 10-g daily consumer dose.

Sourcedoi:10.1113/EP092106PMID 39207908PMC12576002

Tendon; null randomized trial

Tier 2

The Effect of Specific Bioactive Collagen Peptides on Tendon Remodeling during 15 wk of Lower Body Resistance Training

Thomas G Balshaw et al. · Medicine & Science in Sports & Exercise · 2023 · 55(11):2083–2095

Double-blind placebo-controlled randomized lower-body resistance training study; One selected proprietary peptide preparation, young male sample and specific program; negative result prevents a universal tendon-benefit claim but does not negate all c

Sourcedoi:10.1249/MSS.0000000000003242PMID 37436929